The single nucleotide variant **rs121913279** is associated with the *TPMT* (thiopurine S-methyltransferase) gene. This variant is also known as **TPMT*3A**, which is a combination of two missense mutations: **c.460G>A (p.Ala154Thr)** and **c.719A>G (p.Tyr240Cys)**. It is one of the most clinically significant variants in pharmacogenomics, particularly in the context of thiopurine drug metabolism.

### Pharmacogenomic Associations:
1. **Thiopurine Drugs**:
   - Thiopurine drugs, such as **azathioprine**, **6-mercaptopurine (6-MP)**, and **thioguanine**, are used to treat conditions like leukemia, inflammatory bowel disease, and autoimmune disorders.
   - Individuals with the *TPMT* rs121913279 variant have **reduced or absent TPMT enzyme activity**, leading to an increased risk of severe **myelosuppression** (bone marrow toxicity) when treated with standard doses of thiopurines.

2. **Clinical Implications**:
   - Patients with this variant are classified as either **intermediate metabolizers** (heterozygous carriers) or **poor metabolizers** (homozygous carriers).
   - Dose adjustments or alternative therapies are recommended for individuals with this variant to avoid toxicity.

3. **Guidelines**:
   - The **Clinical Pharmacogenetics Implementation Consortium (CPIC)** and other pharmacogenomic guidelines recommend genotyping for *TPMT* variants, including rs121913279, before initiating thiopurine therapy.
   - For poor metabolizers, thiopurine drugs should either be avoided or used at significantly reduced doses.

---

### 薬理ゲノミクス関連性:
1. **チオプリン系薬剤**:
   - **アザチオプリン**、**6-メルカプトプリン (6-MP)**、**チオグアニン**などのチオプリン系薬剤は、白血病、炎症性腸疾患、自己免疫疾患の治療に使用されます。
   - *TPMT*遺伝子のrs121913279変異を持つ個人は、**TPMT酵素活性が低下または欠損**しており、通常のチオプリン投与量で重篤な**骨髄抑制**（骨髄毒性）のリスクが高まります。

2. **臨床的意義**:
   - この変異を持つ患者は、**中間代謝型**（ヘテロ接合体）または**低代謝型**（ホモ接合体）に分類されます。
   - 毒性を回避するために、投与量の調整や代替療法が推奨されます。

3. **ガイドライン**:
   - **臨床薬理ゲノミクス実装コンソーシアム (CPIC)** などの薬理ゲノミクスガイドラインでは、チオプリン療法を開始する前に、rs121913279を含む*TPMT*変異の遺伝子型検査を推奨しています。
   - 低代謝型の場合、チオプリン系薬剤は回避するか、大幅に減量して使用する必要があります。

If you need further details or specific clinical recommendations, feel free to ask!  
詳細や具体的な臨床推奨について知りたい場合は、お気軽にお尋ねください！